It would be good to know who this company is ABLM so we can understand just how advanced they are. They must have several products generating royalty streams to have hit that mkt cap . Suda would look oh so much better with a couple of things occuring namely a Teva and Mitsubishi milestone payment and royalty commencement guideline and some news on Strides. Also progress regarding Anagrelide who be a bonus and of course there are the Ordesa and Sanofi plates spinning too in the background. It remains high in potential but you cant help but feel big pharmas are still giving them the run around.
Getting out, page-22
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $38.90K | 263.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 624656 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 628807 | 7 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |